Karen Bergman | VP of IR and Corporate Communications |
Tom Neff | CEO |
Seth Porter | VP, Fibrosis Program |
Peony Yu | CMO |
Pat Cotroneo | CFO |
Elias Kouchakji | VP, Clinical Development, Drug Safety and Pharmacovigilance |
Michael Yee | Jefferies |
Geoffrey Porges | Leerink |
Andy Hsieh | William Blair |
Joel Beatty | Citi |
Welcome to the FibroGen, Incorporated Third Quarter 2017 Financial Results Conference Call. My name is Adrien and I'll be your operator for today. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] Please note that this conference is being recorded.